Showing results (721-730 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|August 20, 2020
Correction to: Calculating and Interpreting ICERs and Net BenefitMike Paulden
Pharmacoeconomics|April 9, 2021
Healthcare Funding Decisions and Real-World Benefits: Reducing Bias by Matching Untreated PatientsPeter Ghijben, Dennis Petrie, Silva Zavarsek, et al.
Pharmacoeconomics|August 15, 2020
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian CancerWei Gao, Dominic Muston, Matthew Monberg, et al.
Pharmacoeconomics|October 18, 2012
A systematic review and critical assessment of health state utilities: weight change and type 2 diabetes mellitusScott Doyle, Andrew Lloyd, Lee Moore, et al.
Pharmacoeconomics|January 18, 2014
The economic burden of skeletal-related events among elderly men with metastatic prostate cancerJ Jayasekera, E Onukwugha, K Bikov, et al.
Pharmacoeconomics|November 12, 2025
Health-Service Costs for the Treatment of Multidrug-Resistant/Rifampicin-Resistant Tuberculosis in South African Children: Application of a Real-World DatasetThomas Wilkinson, Arne von Delft, Anneke C Hesseling, et al.
Pharmacoeconomics|November 10, 2025
Improving Collaborative Engagement in Health State Valuation: A Scoping Review of Current Practices and Emerging RecommendationsPhilip A Powell, Victoria Gale, Gurdas Singh, et al.
Pharmacoeconomics|November 10, 2025
Individualized Treatment Rules Based on Cost-Effectiveness Criteria in MicrosimulationsNiklaus Meier, Ana Cecilia Quiroga Gutierrez, Mark Pletscher, et al.
Pharmacoeconomics|July 19, 2025
The Burden of Informal Caregiving for Adults with Musculoskeletal Conditions: A Systematic ReviewNanati Legese Alemu, Neha Das, Jennifer J Watts, et al.
Pharmacoeconomics|July 27, 2025
Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology AssessmentsJörg Tomeczkowski, Tanja Heidbrede, Birte Eichinger, et al.
Pageof 335